NEXTCURE INC (NXTC:NASDAQ)
$2.09 -0.14 (-6.278%)
Analysed NEXTCURE INC (NXTC:NASDAQ) News Sources
NextCure to Present at the Piper Sandler 37th Annual Healthcare Conference
20-11-2025
yahoo.com
NextCure Provides Business Update
23-01-2026
yahoo.com
NextCure Provides Business Update and Reports Full Year 2025 Financial Results
05-03-2026
yahoo.com
NextCure and Simcere’s SIM0505 (CDH6 ADC) Abstract Accepted for ASCO 2026
31-03-2026
yahoo.com
NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer
07-04-2026
yahoo.com
NextCure and Simcere’s SIM0505 (CDH6 ADC) Phase 1 Data to be Presented at ASCO 2026
21-04-2026
yahoo.com
NextCure and Simcere Zaiming Initiate Dose Optimization for SIM0505 (CDH6 ADC) in Gynecologic Cancers
04-05-2026
yahoo.com
NextCure Provides Business Update and Reports First Quarter 2026 Financial Results
07-05-2026
yahoo.com
NextCure Presents Positive SIM0505 Phase 1 Dose Escalation Data in Patients with Gynecologic Cancers at ASCO 2026
01-06-2026
yahoo.com
NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancers
04-06-2026
yahoo.com
What is the current price of NEXTCURE INC (NXTC:NASDAQ)?
The current price of NEXTCURE INC (NXTC:NASDAQ) is $2.09.
NEXTCURE INC (NXTC:NASDAQ) absolute price change since previous trading day?
The absolute price change of NEXTCURE INC (NXTC:NASDAQ) since the previous trading day is $-0.14.
NEXTCURE INC (NXTC:NASDAQ) percentage price change since previous trading day?
The percentage price change of NEXTCURE INC (NXTC:NASDAQ) since the previous trading day is -6.278%.
What is the most recent average sentiment score for NEXTCURE INC (NXTC:NASDAQ)?
The most recent average sentiment score for NEXTCURE INC (NXTC:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for NEXTCURE INC (NXTC:NASDAQ)?
The most recent sentiment for NEXTCURE INC (NXTC:NASDAQ) is .
SEC-8K** Filing Available For NEXTCURE INC (NXTC:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.